Pathological Changes After Autologous Formalin-Fixed Tumor Vaccine Therapy Combined With Temozolomide for Glioblastoma -Three Case Reports--Reference-Cited by-同舟云学术

Pathological Changes After Autologous Formalin-Fixed Tumor Vaccine Therapy Combined With Temozolomide for Glioblastoma -Three Case Reports-

Published:2011 Issue:4 Volume:51 Page:319-325
ISSN:0470-8105
Container-title:Neurologia medico-chirurgica
language:en
Short-container-title:Neurol. Med. Chir.(Tokyo)

Author:

SAKAMOTO Noriaki¹,ISHIKAWA Eiichi¹,YAMAMOTO Tetsuya¹,SATOMI Kaishi²,NAKAI Kei¹,SATO Masayuki¹,ENOMOTO Takao³,MORISHITA Yukio²,TAKANO Shingo¹,OHNO Tadao⁴,TSUBOI Koji⁵,MATSUMURA Akira¹

Affiliation:

1. Department of Neurosurgery, Graduate School of Comprehensive Human Sciences, University of Tsukuba

2. Department of Pathology, Institute of Basic Medical Sciences, University of Tsukuba

3. Department of Neurosurgery, Tsukuba Central Hospital

4. Advanced Research Institute for Science and Engineering, Waseda University

5. Proton Medical Research Center, Graduate School of Comprehensive Human Sciences, University of Tsukuba

Publisher

Japan Neurosurgical Society

Subject

Neurology (clinical),Surgery

Link

http://www.jstage.jst.go.jp/article/nmc/51/4/51_4_319/_pdf

Reference24 articles.

1. Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model

2. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner

3. Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study

4. X-irradiation to human malignant glioma cells enhances the cytotoxicity of autologous killer lymphocytes under specific conditions

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful monotherapy with autologous formalin‐fixed tumor vaccine for a Stage IV uterine cancer patient who rejected rational chemotherapy and immune checkpoint inhibitor treatment;Clinical Case Reports;2023-06

2. The immunosuppressive microenvironment and immunotherapy in human glioblastoma;Frontiers in Immunology;2022-11-17

3. “Security Dilemma”: Active Immunotherapy before Versus after Radiation Therapy Alone or Chemo-Radiotherapy for Newly Diagnosed Glioblastoma;Folia Medica;2022-04-30

4. Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment;Cancers;2020-07-19

5. Rate of Clinical Complete Response for 1 Year or More in Bone-Metastatic Breast Cancer after Comprehensive Treatments including Autologous Formalin-Fixed Tumor Vaccine;International Journal of Breast Cancer;2018